Literature DB >> 8794390

Infection of chimpanzee peripheral blood mononuclear cells by human immunodeficiency virus type 1 requires cooperative interaction between multiple variable regions of gp120.

M W Cho1, R Shibata, M A Martin.   

Abstract

We have recently reported the isolation and molecular cloning of a human immunodeficiency virus type 1 isolate (HIV-1 DH125) that exhibits rapid replication kinetics and marked cytopathicity in both human and chimpanzee peripheral blood mononuclear cells (PBMC). To identify the viral determinants responsible for infectivity of chimpanzee PBMC, chimeric viruses containing the following components were constructed: (i) the entire envelope gene; (ii) gp120 sequences; (iii) gp41 sequences; and (iv) individual or various combinations of the gp120 variable regions of HIV-1 DH125 inserted into the backbone of another HIV-1 isolate (HIV-1 AD8), which is unable to infect chimpanzee PBMC. Analyses of virus replication kinetics in human and chimpanzee PBMC revealed that gp120 contains determinants which confer infectivity for chimpanzee PBMC and that the capacity to establish such an infection requires the cooperative interaction between multiple variable regions of the HIV-1 DH125 gp120.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8794390      PMCID: PMC190796     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes.

Authors:  P Westervelt; H E Gendelman; L Ratner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

2.  Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region.

Authors:  R Wyatt; M Thali; S Tilley; A Pinter; M Posner; D Ho; J Robinson; J Sodroski
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

3.  Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions.

Authors:  T S Theodore; G Englund; A Buckler-White; C E Buckler; M A Martin; K W Peden
Journal:  AIDS Res Hum Retroviruses       Date:  1996-02-10       Impact factor: 2.205

Review 4.  Nonhuman primate models for AIDS.

Authors:  P N Fultz
Journal:  Clin Infect Dis       Date:  1993-08       Impact factor: 9.079

5.  Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants.

Authors:  H Schuitemaker; L Meyaard; N A Kootstra; R Dubbes; S A Otto; M Tersmette; J L Heeney; F Miedema
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

6.  Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene.

Authors:  T Shioda; J A Levy; C Cheng-Mayer
Journal:  Nature       Date:  1991-01-10       Impact factor: 49.962

7.  Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120.

Authors:  E O Freed; M A Martin
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

8.  Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization.

Authors:  A Koito; G Harrowe; J A Levy; C Cheng-Mayer
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

9.  Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.

Authors:  S Modrow; B H Hahn; G M Shaw; R C Gallo; F Wong-Staal; H Wolf
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

10.  A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes.

Authors:  S K Ghosh; P N Fultz; E Keddie; M S Saag; P M Sharp; B H Hahn; G M Shaw
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

View more
  9 in total

1.  Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques.

Authors:  M W Cho; Y B Kim; M K Lee; K C Gupta; W Ross; R Plishka; A Buckler-White; T Igarashi; T Theodore; R Byrum; C Kemp; D C Montefiori; M A Martin
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection.

Authors:  Yea-Lih Lin; Clement Mettling; Pierre Portales; Jacques Reynes; Jacques Clot; Pierre Corbeau
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

3.  N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism.

Authors:  R A Ogert; M K Lee; W Ross; A Buckler-White; M A Martin; M W Cho
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4.

Authors:  M W Cho; M K Lee; M C Carney; J F Berson; R W Doms; M A Martin
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus.

Authors:  Y Endo; T Igarashi; Y Nishimura; C Buckler; A Buckler-White; R Plishka; D S Dimitrov; M A Martin
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Identification of gp120 regions targeted by a highly potent neutralizing antiserum elicited in a chimpanzee inoculated with a primary human immunodeficiency virus type 1 isolate.

Authors:  M W Cho; M K Lee; C H Chen; T Matthews; M A Martin
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  The quality of chimpanzee T-cell activation and simian immunodeficiency virus/human immunodeficiency virus susceptibility achieved via antibody-mediated T-cell receptor/CD3 stimulation is a function of the anti-CD3 antibody isotype.

Authors:  Frederic Bibollet-Ruche; Brett A McKinney; Alexandra Duverger; Frederic H Wagner; Aftab A Ansari; Olaf Kutsch
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

8.  Baseline resistance of primary human immunodeficiency virus type 1 strains to the CXCR4 inhibitor AMD3100.

Authors:  Jessamina E Harrison; Jonathan B Lynch; Luz-Jeannette Sierra; Leslie A Blackburn; Neelanjana Ray; Ronald G Collman; Robert W Doms
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

9.  Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytes.

Authors:  Julie M Decker; Kenneth P Zammit; Juliet L Easlick; Mario L Santiago; Denise Bonenberger; Beatrice H Hahn; Olaf Kutsch; Frederic Bibollet-Ruche
Journal:  Virology       Date:  2009-09-12       Impact factor: 3.616

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.